Costas Vamvakas, CEO of VK PREMIUM Business Consultants LTD, was a guest speaker, presenting the favorable investment opportunities in Greece, during the conference Cannabis Business Europe 2019 in Cologne, Germany.
Medical Cannabis industry professionals coming from at least 14 different countries, spoke at this year’s Cannabis Business Europe 2019 conference, focusing on the development of the European medical cannabis markets.
Costas Vamvakas, spoke on the topic “Regulation and Business Strategy”, exhibiting showcasing to all leaders along the Medical Cannabis value chain, why Greece is defined as from various industries, covering areas such as:
VK PREMIUM is a consulting group, and a main stream of its services focuses on facilitating the deployment of Medical Cannabis investments in Greece.
The medicinal cannabis market is undergoing rapid and radical changes. It is estimated that the worldwide turnover for medical cannabis is expected to be quadruple in the next three 3 years.
Moreover, according to Prohibition Partners European Cannabis, until 2028, the value of Greek Medical Cannabis market will reach 900 million euro.
In light of the developments above, the Cannabis Business Europe 2019 showcased the best practices on topics concerning the present and future of the industry, regulation, investment opportunities, production, distribution and business strategy in Europe.
The VK Medical Cannabis division of VK PREMIUM Group, has a concrete expertise in both licensing and business plans development.